|
|
US 7,572,915 B2 |
|
| Quinoline derivatives as phosphodiesterase inhibitors |
| Michael David Barker, Stevenage (United Kingdom); Anthony William Dean, Stevenage (United Kingdom); Brian Evans, Stevenage (United Kingdom); Stuart Holman, Stevenage (United Kingdom); and Michael Woodrow, Stevenage (United Kingdom) |
| Assigned to Glaxo Group Limited, Greenford, Middlesex (United Kingdom) |
| Filed on Feb. 08, 2006, as Appl. No. 11/349,677. |
| Application 11/349677 is a continuation of application No. 10/557079, previously published as PCT/EP2004/005494, filed on May 19, 2004. |
| Claims priority of application No. 0311688.6 (GB), filed on May 21, 2003; and application No. 0326187.4 (GB), filed on Nov. 10, 2003. |
| Prior Publication US 2006/0178416 A1, Aug. 10, 2006 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07D 215/38 (2006.01)
|
